What’s News in Earnings: How Big Pharma Is Expanding the GLP-1 Market

Bonus Episode for May 8. Financial results from pharmaceutical companies Eli Lilly, Novo Nordisk, Merck, Bristol Myers Squibb and AbbVie show strong demand continuing for weight-loss drugs and autoimmune treatments. Wall Street Journal pharma reporter Peter Loftus discusses which drugmakers have the upper hand in the race to dominate those markets. WSJ Heard on the Street columnist David Wainer hosts this special bonus episode of What's News in Earnings, where we dig into companies’ earnings reports and analyst calls to find out what’s going on under the hood of the American economy. Sign up for the WSJ's free Markets A.M. newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

You can listen to What’s News in Earnings: How Big Pharma Is Expanding the GLP-1 Market online on Radio and Podcast. Open the player on this page to stream the available audio.

What’s News in Earnings: How Big Pharma Is Expanding the GLP-1 Market is an episode from WSJ What’s News by The Wall Street Journal.

This episode is 6:34 long.

This episode was published on May 8, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from WSJ What’s News when more episodes are available from the podcast feed.